At this historic gathering, the global psychedelic science community will come together to celebrate the progress we've made since our founding, and to help build the future of psychedelic medicine with a fundraiser to support our $400,000 purchase of one kilogram of pharmaceutical grade (GMP) MDMA for Phase 3 clinical trials and other research around the world.
David Bronner is President of Dr. Bronner’s Magic Soaps. He is a grandson of company founder, Emanuel Bronner, and a fifth-generation soapmaker. Under David’s leadership, in 2003, Dr. Bronner’s was one of the first brands to certify their soaps, lotions and balms under the USDA National Organic Program. Today Dr. Bronner’s is coordinating certified Fair Trade projects for all major ingredients, including olive oil from the West Bank and Israel, coconut oil from Sri Lanka, and palm oil from Ghana. David pioneered the use of 100% post-consumer recycled PET bottles for the liquid soaps and a hemp/recycled paper blend to package the bars. David was the main coordinator of the Hemp Industries Association’s successful multi-year litigation against the Drug Enforcement Administration (DEA) to protect sales of hemp foods and body care in the U.S. (2001-2004). He is an active supporter of both the Hemp Industries Association (HIA) and Vote Hemp, working to bring back hemp farming in the U.S. David was born in Los Angeles in 1973 and now lives in Encinitas, California with his wife Kris and daughter Maya. He enjoys coaching his daughter’s soccer team and dancing late into the night.
Brad earned his B.A. in Communication and Psychology from Stanford University in 2005 and his M.A. in Communication from the University of California, San Diego in 2009. His graduate work focused on the political, scientific, and cultural changes required to make illicit drugs into legitimate medicines. He has also interned for the Drug Policy Alliance and has a longstanding interest in drug policy reform and activism. He began working with MAPS as an intern in 2009, joining the staff in January 2011. Brad is also a consultant, writer, and editor for organizations and individuals working in psychedelic and medical marijuana research, drug policy, and psychedelic therapy. He believes in the importance of communication for sharing knowledge and building community, and is committed to helping people develop honest and responsible relationships with themselves, each other, and their pharmacological tools.
Rick Doblin is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment.
Amy Emerson, Executive Director and Director of Clinical Research (MPBC)
Amy earned her BS in genetics and cell biology from Washington State University in 1992. Prior to her work at the Multidisciplinary Association for Psychedelic Studies (MAPS) and MAPS Public Benefit Corporation (MPBC) she worked in clinical development and research beginning in 1993. Amy's previous experience is in the fields of immunology (Applied Immune Sciences), oncology (RPR), and vaccine development (Chiron and Novartis). Amy worked with MAPS as a volunteer starting in 2003 facilitating the development of the MDMA clinical program. In 2009, she began managing the Clinical Research group at MAPS. She is currently the Executive Director and Director of Clinical Research of MAPS Public Benefit Corporation.
Michael Mithoefer MD
Michael Mithoefer, M.D., Lead Clinical Investigator and Medical Monitor, MDMA-Assisted Psychotherapy for PTSD
Michael Mithoefer, M.D., is a psychiatrist practicing in Charleston, SC, where he divides his time between clinical research and outpatient clinical practice specializing in treating posttraumatic stress disorder (PTSD) with an emphasis on experiential methods of psychotherapy. He is a Grof-certified Holotropic Breathwork Facilitator and is trained in EMDR and Internal Family Systems Therapy. He and his wife, Annie Mithoefer, recently completed a MAPS-sponsored Phase II clinical trial testing MDMA-assisted psychotherapy for PTSD. A paper about their study was published in July 2010 in the Journal of Psychopharmacology. They are currently conducting a second trial with veterans who have PTSD resulting from service in the U.S. Armed Forces, as well as psychotherapy training programs for MAPS researchers. Dr. Mithoefer is the medical monitor for MAPS-sponsored clinical trials in Europe, the Middle East, Canada, and Colorado. Before going into psychiatry in 1995 he practiced emergency medicine for ten years, served as medical director of the Charleston County and Georgetown County Emergency Departments, and has held clinical faculty positions at the Medical University of South Carolina. He is currently board certified in Psychiatry, Emergency Medicine, and Internal Medicine.
Jade Netanya Ullmann
Jade Netanya Ullmann, Development Officer
Jade Netanya Ullmann is a seasoned fundraiser, philanthropist, activist, and community organizer. She is the former executive director of Romemu, a progressive Jewish spiritual community in New York City. Jade is an ambassador for the Social Venture Network, a nonprofit network of business leaders committed to justice and sustainability, as well as a member of the Threshold Foundation, which is dedicated to mobilizing financial resources to change the world. She currently serves on the Board of Directors of Romemu, as well as ALEPH: The Alliance for Jewish Renewal, and on the Advisory Board of Bernie Glassman’s Zen Peacemaker Order. She received her B.A. in contemplative psychology from Naropa University, where she was the campus organizer of Students for a Free Tibet. She began working with MAPS in early 2015 to expand the organization’s community visibility, and has since joined the staff as Major Gifts Officer. Jade is enthusiastic about inspiring others to recognize and support the visionary research and healing work of MAPS. She lives in New York City, where she was born and raised.